Children and Parents With ADHD and Related Disorders (ChiP-ARD)

This study has been completed.
Sponsor:
Information provided by (Responsible Party):
Centre Hospitalier Universitaire de Nice
ClinicalTrials.gov Identifier:
NCT01260792
First received: December 14, 2010
Last updated: March 23, 2012
Last verified: September 2009
  Purpose

Almost all rating scales for Attention-Deficit/Hyperactivity Disorder (ADHD) are not validated in France. This clearly hampers the development of the diagnosis and the monitoring of patients but also research in this domain. This study is conceived to collect data in the general population of children aged from 4 to 18 years in public schools in the city of Nice.

Children are pseudo-randomly selected from classes of randomly selected schools in the city of Nice (France). Teachers fill out questionnaires using a dedicated secured website, and ask parents to fill out a similar set of questionnaires regarding their child's behaviour at home. Since ADHD has a strong genetic components, parents are also asked to fill out questionnaires regarding their own behaviour at adulthood and in childhood retrospectively.

Additionally, known factors related to ADHD and other disorders as well as other putative factors are tested in the epidemiologic study.


Condition Intervention
General Population
TDAH
Children Aged 5 to 18 Years
Other: questionnaire
Other: Questionnaire

Study Type: Observational
Study Design: Time Perspective: Prospective
Official Title: Validation and Norms for Attention Deficit/Hyperactivity Disorder Scales in Children and Adults. Description of Associated Factors.

Resource links provided by NLM:


Further study details as provided by Centre Hospitalier Universitaire de Nice:

Primary Outcome Measures:
  • Validity of studied instruments [ Time Frame: at time=0 ] [ Designated as safety issue: No ]
    The only criterion of evaluation towards the type of the study and its main objective is Validity of the studied instruments


Enrollment: 2600
Study Start Date: February 2010
Study Completion Date: December 2011
Primary Completion Date: July 2011 (Final data collection date for primary outcome measure)
Groups/Cohorts Assigned Interventions
Children
Children between 5 and 18 years old.
Other: questionnaire
The teachers or the professors complete questionnaires on the child on their behavior in classes
Adults
Parents of children between 5 and 18 years old
Other: Questionnaire
The parents complete a questionnaire on the behavior of their child and on their own behavior

  Eligibility

Ages Eligible for Study:   5 Years to 18 Years
Genders Eligible for Study:   Both
Accepts Healthy Volunteers:   Yes
Sampling Method:   Probability Sample
Study Population

Two non-independant study groups: children aged 5 to 18, and at least one of their parents

Criteria

Inclusion Criteria:

  • Child known for the teacher for at least three months so that his evaluation Reflect most faithfully possible the usual behavior of the child,
  • Child having the Frenchman for mother tongue to avoid the consequences on him Behavior of a linguistic obstacle,
  • Authorization to use the data signed by at least one of the parents of the child and by the very child when he is old at least of six years.
  • Parents speaking and reading the Frenchman.

Exclusion Criteria:

  • Child known to follow a specific treatment of a disorder(confusion)attentional with / without Hyperactivity-impulsiveness (eg. Ritaline Ò, Ritaline Ò LP, Arranged Ò LP, Strattera Ò) Whatever is its duration. Indeed, a selection on this criterion would introduce a way Major which(who) would return the less reliable results(profits) of the study.
  • Child presenting a known neurological or psychiatric disorder, or a deficit Intellectual because the attentional disorders(confusions), the psychomotor excitement and The impulsiveness can be symptoms inherent to the other pathologies Neurological and\or psychiatric.
  Contacts and Locations
Choosing to participate in a study is an important personal decision. Talk with your doctor and family members or friends about deciding to join a study. To learn more about this study, you or your doctor may contact the study research staff using the Contacts provided below. For general information, see Learn About Clinical Studies.

Please refer to this study by its ClinicalTrials.gov identifier: NCT01260792

Locations
France
CHU de Nice
Nice, France, 06000
Sponsors and Collaborators
Centre Hospitalier Universitaire de Nice
Investigators
Principal Investigator: Hervé CACI, PH CHU de Nice
  More Information

No publications provided by Centre Hospitalier Universitaire de Nice

Additional publications automatically indexed to this study by ClinicalTrials.gov Identifier (NCT Number):
Responsible Party: Centre Hospitalier Universitaire de Nice
ClinicalTrials.gov Identifier: NCT01260792     History of Changes
Other Study ID Numbers: 09-APN-02
Study First Received: December 14, 2010
Last Updated: March 23, 2012
Health Authority: France: French Data Protection Authority

Additional relevant MeSH terms:
Attention Deficit Disorder with Hyperactivity
Attention Deficit and Disruptive Behavior Disorders
Mental Disorders Diagnosed in Childhood
Mental Disorders

ClinicalTrials.gov processed this record on August 01, 2014